Skip to main content
. Author manuscript; available in PMC: 2024 May 15.
Published in final edited form as: J Ethnopharmacol. 2022 Mar 1;291:115159. doi: 10.1016/j.jep.2022.115159

Table 3.

In vitro CYP3A4 inhibition by phytochemicals of T. crispa and T. sinensis.

Plant Source Test sample CYP 3A4 Inhibition - IC50 (μg/mL)

T. crispa Methanolic extract 5.90 ± 1.22
T. crispa Borapetoside B 100.0 ± 0.00
T. crispa Borapetoside C 37.50 ± 12.27
T. crispa Borapetoside F 13.00 ± 0.82
T. crispa (2R, 5R,6R,8R,9S,10S, 12S) –15,16-epoxy-2-hydroxy-6-O-(β-D-glucopyranosyl) -cleroda-3,13(16), 14-trien-17,12-olid-18-oic acid methyl ester 29.00 ± 0.82
T. crispa N-trans-feruloyl tyramine 2.70 ± 0.08
T.crispa Palmatine 34.00 ± 0.00
T. sinensis Methanolic extract 8.90 ± 0.73
T. sinensis Tinosineside A 45.00 ± 5.72
T. sinensis Tinosinen >100
Berberine 0.72 ± 0.17
Jatrorrhizine 9.50 ± 2.29
Magnoflorine 36.00 ± 3.27
Positive control Ketoconazole 0.03 ± 0.01